



structural communications
Structure of the first representative of Pfam family PF09410 (DUF2006) reveals a structural signature of the calycin superfamily that suggests a role in lipid metabolism
aJoint Center for Structural Genomics, https://www.jcsg.org , USA,bStanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory,
Menlo Park, CA, USA,cProgram on Bioinformatics and Systems Biology, Burnham Institute for Medical Research,
La Jolla, CA, USA,dLehrstuhl für Biologische Chemie, Technische Universität München, 85350 Freizing-Weihenstephan,
Germany,eDepartment of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann
Arbor, MI 48109-1065, USA,fDepartment of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA,gCenter for Research in Biological Systems, University of California, San Diego, La
Jolla, CA, USA,hProtein Sciences Department, Genomics Institute of the Novartis Research Foundation,
San Diego, CA, USA, and iPhoton Science, SLAC National Accelerator Laboratory, Menlo Park, CA, USA
*Correspondence e-mail: [email protected]
The first structural representative of the domain of unknown function DUF2006 family, also known as Pfam family PF09410, comprises a lipocalin-like fold with domain duplication. The finding of the calycin signature in the N-terminal domain, combined with remote sequence similarity to two other protein families (PF07143 and PF08622) implicated in isoprenoid metabolism and the oxidative stress response, support an involvement in lipid metabolism. Clusters of conserved residues that interact with ligand mimetics suggest that the binding and regulation sites map to the N-terminal domain and to the interdomain interface, respectively.
Keywords: structural genomics; domains of unknown function; calycin; lipocalin; fatty-acid binding proteins.
3D view: 2ich
PDB reference: NE1406 from N. europaea, 2ich, r2ichsf
1. Introduction
In an effort to extend the structural coverage of proteins for which the biological
function is unknown and cannot be deduced by homology (domains of unknown function;
DUFs), targets were selected from Pfam protein family PF09410 (DUF2006). Here, we
report the et al., 2002) as part of the NIGMS Protein Structure Initiative (PSI). The NE1406 gene of Nitrosomonas europaea, an obligate chemolithoautotroph, encodes a protein with a molecular weight of 40.1 kDa
(residues 1–356) and a calculated of 5.0.
2. Materials and methods
2.1. Protein production and crystallization
Clones were generated using the polymerase incomplete primer extension (PIPE) cloning
method (Klock et al., 2008). The gene encoding NE1406 (GenBank NP_841447, gi|30249377, Swiss-Prot Q82US3) was
amplified by (PCR) from N. europaea strain ATCC 19718 genomic DNA using PfuTurbo DNA polymerase (Stratagene) and I-PIPE (Insert) primers (forward primer 5′-ctgtacttccagggcATGCGTTACTTATGGATACTGTTG-3′,
reverse primer 5′-aattaagtcgcgttaCATCGATAACGGACGTACG-3′; target sequence in upper
case) that included sequences for the predicted 5′ and 3′ ends. The expression vector
pSpeedET, which encodes an amino-terminal tobacco etch virus (TEV) protease-cleavable
expression and purification tag (MGSDKIHHHHHHENLYFQ/G), was PCR-amplified with V-PIPE
(Vector) primers. V-PIPE and I-PIPE PCR products were mixed to anneal the amplified
DNA fragments together. Escherichia coli GeneHogs (Invitrogen) competent cells were transformed with the V-PIPE/I-PIPE mixture
and dispensed onto selective LB-agar plates. The cloning junctions were confirmed
by DNA sequencing. Using the PIPE method, the part of the gene encoding residues Met1–Pro22
was deleted. Expression was performed in a selenomethionine-containing medium with
suppression of normal methionine synthesis. At the end of lysozyme was added to the culture to a final concentration of 250 µg ml−1 and the cells were harvested and frozen. After one freeze–thaw cycle, the cells were
sonicated in lysis buffer [50 mM HEPES pH 8.0, 50 mM NaCl, 10 mM imidazole, 1 mM tris(2-carboxyethyl)phosphine–HCl (TCEP)] and the lysate was clarified by centrifugation
at 32 500g for 30 min. The soluble fraction was passed over nickel-chelating resin (GE Healthcare)
pre-equilibrated with lysis buffer, the resin was washed with wash buffer [50 mM HEPES pH 8.0, 300 mM NaCl, 40 mM imidazole, 10%(v/v) glycerol, 1 mM TCEP] and the protein was eluted with elution buffer [20 mM HEPES pH 8.0, 300 mM imidazole, 10%(v/v) glycerol, 1 mM TCEP]. The was buffer-exchanged with TEV buffer (20 mM HEPES pH 8.0, 200 mM NaCl, 40 mM imidazole, 1 mM TCEP) using a PD-10 column (GE Healthcare) and incubated with 1 mg TEV protease per
15 mg of eluted protein. The protease-treated was run over nickel-chelating resin (GE Healthcare) pre-equilibrated with HEPES crystallization
buffer (20 mM HEPES pH 8.0, 200 mM NaCl, 40 mM imidazole, 1 mM TCEP) and the resin was washed with the same buffer. The flowthrough and wash fractions
were combined and concentrated by centrifugal ultrafiltration (Millipore) to 19.4 mg ml−1 for crystallization trials. NE1406 was crystallized using the nanodroplet vapor-diffusion
method (Santarsiero et al., 2002
) with standard JCSG crystallization protocols (Lesley et al., 2002
). Sitting drops composed of 200 nl protein mixed with 200 nl crystallization solution
were equilibrated against a 50 µl reservoir at 293 K for 50 d prior to harvest. The
crystallization reagent consisted of 1.4 M ammonium sulfate and 0.1 M CHES [2-(N-cyclohexylamino)ethanesulfonic acid] pH 9.0. Glycerol was added to the crystal to
a final concentration of 10%(v/v) as a cryoprotectant. Initial screening for diffraction was carried out using the
Stanford Automated Mounting system (SAM; https://smb.slac.stanford.edu/facilities/hardware/SAM/UserInfo ; Cohen et al., 2002
) at the Stanford Synchrotron Radiation Lightsource (SSRL; Menlo Park, California,
USA). Diffraction data from a plate-shaped crystal with approximate dimensions 0.2
× 0.1 × 0.05 mm mounted in a nylon loop were indexed in the orthorhombic P212121 (Table 1
). The oligomeric state of NE1406 was determined to be a monomer using a 0.8 × 30 cm
Shodex Protein KW-803 column (Thomson Instruments) pre-calibrated with gel-filtration
standards (Bio-Rad). Protein concentrations were determined using the Coomassie Plus
assay (Pierce).
![]() ![]() ‡Typically, the number of unique reflections used in is slightly less that the total number that were integrated and scaled. Reflections are excluded owing to negative intensities and rounding errors in the resolution limits and unit-cell parameters. §Rcryst = ![]() ![]() ¶Rfree is the same as Rcryst but for 5.1% of the total reflections chosen at random and omitted from ††This value represents the total B that includes TLS and residual B components. ‡‡Estimated overall coordinate error (Collaborative Computational Project, Number 4, 1994 ![]() ![]() §§Two CHES and three glycerol molecules. |
2.2. Data collection, structure solution and refinement
Multiple-wavelength anomalous diffraction (MAD) data were collected at the APS on
beamline 23-ID-D at wavelengths corresponding to the inflection (λ1), high-energy remote (λ2) and peak (λ3) points of the Se K The data sets were collected at 100 K using a MAR Mosaic300 CCD detector (Rayonix).
The MAD data were integrated and reduced using MOSFLM (Leslie, 1992) and scaled with the program SCALA (Collaborative Computational Project, Number 4, 1994
). Phasing was performed with SOLVE (Terwilliger & Berendzen, 1999
), with a mean figure of merit of 0.28 with eight selenium sites (no selenium site
was found for the disordered C-terminal SeMet356 for either chain). Density modification
with RESOLVE (Terwilliger, 2002
) was followed by automated model building with ARP/wARP (Cohen et al., 2004
). Model completion and were carried out with Coot (Emsley & Cowtan, 2004
) and REFMAC 5.2 (Winn et al., 2003
) using data set λ1. included experimental phase restraints in the form of Hendrickson–Lattman coefficients
from SOLVE, NCS restraints (positional weights of 0.5 and 5.0 and thermal weights of 2.0 and
10.0 for the main-chain and side-chain atoms, respectively) and TLS with one group per chain. NCS restraints were applied as two sets: to the N-terminal
residues 24–74 and the C-terminal residues 83–351. Data-collection and are summarized in Table 1
.
2.3. Validation and deposition
Analysis of the stereochemical quality of the model was accomplished using AutoDepInputTool (Yang et al., 2004), MolProbity (Davis et al., 2007
), SFCHECK 4.0 (Collaborative Computational Project, Number 4, 1994
) and WHAT IF 5.0 (Vriend, 1990
). Protein was analyzed using the PISA server (Krissinel & Henrick, 2007
). Fig. 1
(b) was adapted from an analysis using PDBsum (Laskowski et al., 2005
) and all other figures were prepared with PyMOL (DeLano Scientific). Atomic coordinates and experimental structure factors for NE1406
at 2.0 Å resolution have been deposited in the PDB with code 2ich .
![]() |
Figure 1 Crystal structure of NE1406 from N. europaea. (a) Stereo ribbon diagram of the NE1406 monomer (chain A) color-coded from the N-terminus (blue) to the C-terminus (red). Helices H1–H3 and β-strands β1–β23 are indicated. (b) Diagram showing the secondary-structure elements of NE1406 (chain A) superimposed on its sequence. The labeling of secondary-structure elements is in accord with PDBsum (https://www.ebi.ac.uk/pdbsum ), where α-helices are sequentially labeled (H1, H2, H3 etc.), β-strands are labeled (A, B, C etc.) according to the β-sheets to which they are assigned, β-turns and γ-turns are designated by Greek letters (β, γ) and β-hairpins by red loops. For NE1406, the 310-helices (H1–H3), β-strands in β-sheets (A and B, comprising strands β1–β13 and β14–β23, respectively ), β-turns (β) and γ-turns (γ) are indicated. Dashed lines indicate sections of sequence in the construct that are not modeled in the structure. |
3. Results and discussion
3.1. Overall structure
The a) was determined to 2.0 Å resolution using the technique. Data-collection, model and are summarized in Table 1
. The final model includes 643 residues in two protein molecules (A and B), two CHES molecules, three glycerol molecules, one sulfate ion and 394 water molecules
in the No electron density was observed for Gly0 (from the purification tag), Val23 (the
first residue after Gly0), Thr75–Pro82 and Arg352–SeMet356 in chain A or for Thr75–Asp80 and Pro353–SeMet356 in chain B. The side-chain atoms of Leu24, Arg144, Glu169, Gln200, Asp222 from chain A and Leu24, Gln89 and Arg352 from chain B were omitted owing to poor electron density. The two chains are nearly identical,
with an r.m.s.d. of 0.30 Å over 320 Cα atoms (0.60 Å over all 2524 equivalent atoms). The Matthews coefficient (VM; Matthews, 1968
) is 2.35 Å3 Da−1 and the estimated solvent content is 47.3%. The Ramachandran plot produced by MolProbity (Davis et al., 2007
) shows that 98 and 100% of the residues are in favored and allowed regions, respectively.
SCOP classifies NE1406 as an all-β protein with an AttH-like fold characterized by two flattened, orthogonally packed,
β-barrels of lipocalin-like topology (https://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.bai.b.b.b.html ). Lipocalins (PF00061) are an increasingly diverse family of predominantly small,
single-domain, secreted proteins exhibiting high affinity and selectivity for hydrophobic
molecules. Structurally, lipocalins form a subset of the calycin superfamily, which
additionally includes avidins and fatty-acid binding proteins (FABPs) (Flower et al., 1993; Pfam clan CL0116). Calycins are an example of a superfamily with members sharing
structural similarities that cannot be detected at the sequence level. The calycin
core fold comprises an eight-stranded calyx-shaped antiparallel β-barrel which opens toward one end, where the binding site is located. In the case
of lipocalins and avidins, the core fold is maintained and differences are observed
in the loop lengths and compactness of the barrel. In FABPs, the core calycin fold
is supplemented by two additional β-strands and two short helices that pack on top of the lipid-binding cavity. In all
cases, a short 310-helix caps the barrel at one end, which is also latched by a conserved cation–π interaction involving a tryptophan from the first β-strand and a lysine or arginine residue from the final β-strand of the barrel. Both of these residues additionally form hydrogen bonds to
main-chain atoms in the 310-helix (Flower et al., 2000
).
The N-terminal domain of NE1406 (residues 24–220) comprises 13 β-strands arranged in the form of a flattened barrel with a 310-helix (H1 in Fig. 1) capping the barrel at one end (Fig. 1
a). The C-terminal domain (residues 221–352) is arranged perpendicular to the long
axis of the N-terminal barrel and comprises ten β-strands. It can be superimposed on the N-terminal domain with a Cα r.m.s.d. of 2.4 Å over 105 residues (Fig. 2
a), suggesting gene duplication, although the sequence identity of only 9% is nonsignificant
(Fig. 2
b). Strands β5–β6 are absent from the C-terminal domain, while β11 is replaced by another 310-helix (H3 in Fig. 2
b). The 310-helix cap of the N-terminal barrel is replaced by two longer strands, β18–β19 (in the C-terminal domain), that extend over one end of the barrel (Figs. 1
a and 2
).
![]() |
Figure 2 NE1406 exhibits domain duplication. (a) Stereo ribbon diagram of the N-terminal domain (residues 24–220, blue) of NE1406 superimposed onto the C-terminal domain (residues 221–352, gray). (b) Structure-guided alignment of the N- and C-terminal domains of NE1406. Secondary-structure elements are indicated in blue and gray for the N- and C-terminal domains, respectively. Identical residues are boxed in orange and conservative substitutions in purple. Ala74 is underlined to denote the eight-residue break in the chain between Ala74 and Ser83. The missing region was not modeled owing to poor electron density and is likely to be flexible. |
3.2. Detection of the calycin superfamily signature
A search with FATCAT (Ye & Godzik, 2004) using the entire NE1406 structure gave no significant hits. Individually, the N-
and C-terminal domains both showed structural similarity to a variety of β-barrel proteins, including outer membrane proteins (PDB codes 2erv , 2jmm , 1k24 and 1p4t ), avidin-related and streptavidin-related proteins (PDB codes 1avd , 1wbi , 1y52 , 2ciq , 2uyw and 1stp ), fatty-acid binding proteins (PDB codes 1g5w and 2q9s ), nitrophorin (PDB codes 1d2u and 1u17 ) and a retinoic acid-binding protein (PDB code 1blr ). The best score was for the outer membrane protein PagL from Pseudomonas aeruginosa (PDB code 2erv ), which gave a Cα r.m.s.d. of 3.4 Å over 198 residues with a sequence identity of only 3%.
This calycin-family signature in NE1406 (Fig. 3b) is conserved in the DUF2006 family. In the N-terminal domain of NE1406, the Arg214
side chain from β13 interacts with main-chain residues in both β1 and the N-terminal 310-helix, whereas hydrogen bonding of the Trp50 indole to the 310-helix is mediated via a glycerol molecule (Fig. 3
b). Although the calycin signature is absent from the NE1406 C-terminal domain (Fig.
2
), its presence in the N-terminal domain served to direct our analysis towards calycin-superfamily
members.
![]() |
Figure 3 Similarities and differences between NE1406 and the calycin superfamily. (a) Stereo ribbon diagram of the binding sites for the two buffer molecules 2-(N-cyclohexylamino)ethanesulfonic acid (CHES) and glycerol (GOL). Conserved residues are indicated. (b) NE1406 exhibits the calycin-superfamily structural signature. Stereo ribbon diagram of the N-terminal domain of NE1406 showing the stacked arginine and tryptophan residues characteristic of the calycin fold (Flower et al., 2000 ![]() |
Analysis of the structural superposition of NE1406 with members of the calycin superfamily
revealed a number of systematic differences (Figs. 3c and 3
d). The β-sheets forming the NE1406 β-barrel are both longer and flatter than those in lipocalins, resulting in a narrower
opening at the bottom of the barrel where the lipocalin-binding site would reside.
The difference is even more pronounced when NE1406 is compared with avidins (PF01382;
Fig. 3
d), which have barrels that are more circular and compact than in lipocalins. In this
respect, NE1406 resembles FABPs, which also exhibit a barrel that is flatter and more
elliptical than in lipocalins. However, NE1406 lacks two additional helices at the
top of the barrel that are a characteristic of FABPs. Secondary-structure elements,
such as the long C-terminal α-helix characteristic of most lipocalin-like calycins, e.g. nitrophorin (PF02087; Flower et al., 2000
; Skerra, 2000
), are also absent from NE1406. Finally, the calycin signature residues are in different
conformations to those typically described for calycins, with Trp50 adopting a different
rotamer in NE1406 than in calycins and Arg214 not adopting a fully extended conformation.
3.3. Similarities and differences with lipocalins
NE1406 is likely to provide the first structural template for two other protein families.
A search with HHpred (Soding et al., 2005) against Pfam gave E values of 1.0 × 10−15 and 1.5 × 10−7 for protein families PF07143 and PF08622, respectively. PF07143 is a prokaryotic
family of hydroxyneurosporene synthases that are implicated in carotene metabolism,
while PF08622 is a family of fungal proteins that inhibit the generation of reactive
oxygen species and promote survival during oxidative stress. The role of in photoprotection in plants (Penuelas & Munne-Bosch, 2005
) and antioxidant defence in other eukaryotes (Tapiero et al., 2004
; Rao & Rao, 2007
) has been well documented. A number of lipocalins, such as apolipoprotein D (ApoD;
Sanchez et al., 2006
; Charron et al., 2008
; Eichinger et al., 2007
), neutrophil gelatinase-associated lipocalin (Roudkenar et al., 2008
; Goetz et al., 2002
) and α1-microglobulin (Olsson et al., 2008
; Schonfeld & Wojtczak, 2008
), provide protection against oxidative stress by means of such as carotene. Other members of the calycin superfamily, such as avidins (PF01382),
are not involved in this response. We therefore searched for other indications that
NE1406 might be related to the lipocalin/cytosolic fatty-acid binding protein family
(PF00061).
Lipocalins have been likened to antibodies because of the high degree of structural
plasticity that their binding sites exhibit, with numerous examples in which structural
consolidation occurs upon binding (for a review, see Skerra, 2008). As a result, the lipocalin fold has been employed in a number of protein-engineering
studies (Beste et al., 1999
; Korndorfer et al., 2003
). In the NE1406 the two lipocalin-like barrels lack the large internal cavity that is typical of
lipocalins and also the long structurally flexible loops at the open end of the β-barrel (Skerra, 2000
). In fact, only one of the β-barrel domains of NE1406 harbors a small glycerol molecule from the crystallization
solution as a ligand. However, the complete internalization of the glycerol molecule
in the NE1406 structure suggests that the N-terminal lipocalin-like barrel might adopt
different conformations in the presence of a natural ligand. We therefore propose
that this region, which encompasses the calycin signature, acts as a ligand-binding
site, the shape and accessibility of which may change with natural ligands.
The ability to form dimers is another feature of the lipocalin family, with ligand
presence influencing et al., 2006). Analytical shows that NE1406 forms a monomer in solution, whereas crystal-packing analysis suggests
a dimer with a total buried surface area of 1290 Å2 per monomer. While it is possible that dimerization of NE1406 is modulated by ligand
binding, the relative orientation of the two protein domains within the polypeptide
chain could also be subject to regulation by a second ligand. The two barrels are
stabilized in a perpendicular orientation with respect to each other. The mainly aromatic
and hydrophobic residues implicated in the interaction with CHES are highly or strictly
conserved among DUF2006 homologs, suggesting that the domain interface plays a functional
role. As with the glycerol molecule bound within the N-terminal barrel, the CHES molecule
is also fully enclosed within NE1406 with no exposure to solvent, suggesting some
flexibility at the interdomain interface to accommodate ligands. Ligand binding at
the domain interface might act to regulate the shape of the binding cavity within
one or both of the β-barrels in a similar manner to the regulation by dimerization observed in lipocalins.
Finally, some lipocalins, such as the bacterial lipocalin (Blc), ApoD and lazarillo,
are known to be peripherally anchored to biological membranes, where they are thought
to play a role in membrane biogenesis and repair (Bishop, 2000; Eichinger et al., 2007
). Expressed under conditions known to exert stress on the bacterial envelope, Blc
from E. coli has a high affinity for lysophospholipids (LPLs), which may also be bound inside
the β-barrel and are thought to be involved in cell-envelope LPL transport (Campanacci
et al., 2006
). Although the exact mechanisms of transperiplasmic movement of between inner and outer membranes are largely unknown, ATP-binding cassette transporters
are involved in this process (Doerrler et al., 2004
).
As expected, a search with PROFtmb (Bigelow et al., 2004) shows that NE1406 is not predicted to be a transmembrane β-barrel (Z score 2.9). However, calculations with the program PPM (Lomize et al., 2006
) suggest weak peripheral association of the protein with membrane. The ligand-binding
cavity of the β-barrel opens towards the membrane surface in the predicted orientation (Supplementary
Fig. 11), similar to ApoD (Eichinger et al., 2007
). The membrane-interacting residues of the protein include the exposed hydrophobic
Phe85 and a large patch of basic residues (Arg46, Arg113, Lys249, Arg284, Arg287,
Arg319 and Arg352).
3.4. Genome-context analysis
The genome context (https://string.embl.de ) of NE1406 shows a predicted functional association with the lipoprotein-releasing system ATP-binding protein LolD (lolD) and co-occurrence with an ATP-binding protein ABC transporter (NE1404). A high degree of confidence is predicted for the functional association of many DUF2006 homologs with ATP-dependent ABC transporters, as well as with other transmembrane proteins including Na+/H+ antiporters, sensor histidine kinases and (e.g. LprI precursor in Mycobacterium tuberculosis). The systematic presence of ATP-dependent cassettes and is compatible with a role for the DUF2006 family in lipid transport, while the presence of numerous signal transduction genes might indicate expression under specific conditions, such as environmental stress. Further experiments will be required in order to functionally characterize NE1406 and to determine whether it associates with in vitro or in vivo and whether its transcription is subject to environmental regulation.
The DUF2006 protein family contains over 400 homologs distributed among trypanosomata,
fungi, mycobacteria, bacteroidetes, rhizobia, Vibrio, spirochaetes, firmicutes and archaea. Given the wide phylogenetic presence of the
DUF2006 family, if an experimental connection to lipocalins is determined, this finding
would present the first evidence of a lipocalin-related protein in the Archaea domain
and would settle the question of whether or not this protein family may have arisen
via horizontal transfer to eukaryotic cells from the endosymbiotic α-proteobacterial ancestor of the mitochondrion (Bishop, 2000).
The availability of more DUF2006 sequences and structures might shed light on the evolutionary history of this intriguing protein family. The information presented here, in combination with further biochemical and biophysical studies, should yield valuable insights into the functional role of NE1406. Models of NE1406 homologs can be accessed at https://www1.jcsg.org/cgi-bin/models/get_mor.pl?key=2ichA .
Additional information about the protein described in this study is available from
TOPSAN (Krishna et al., 2010) at https://www.topsan.org/explore?PDBid=2ich .
4. Conclusions
NE1406 adopts a lipocalin-like fold with domain duplication. Analysis based on the calycin-superfamily signature present in the N-terminal domain reveals a potential binding site, while remote sequence homology and the genome context suggest involvement in isoprenoid metabolism and survival under oxidative stress.
Supporting information
3D view: 2ich
PDB reference: NE1406 from N. europaea, 2ich, r2ichsf
Supporting information file. DOI: 10.1107/S1744309109037749/wd5116sup1.pdf
Acknowledgements
This work was supported by National Institutes of General Medical Sciences Protein Structure Initiative grant No. U54 GM074898. Portions of this research were carried out at the Advanced Photon Source (APS) and SSRL. GM/CA CAT has been funded in whole or in part by Federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science under contract No. DE-AC02-06CH11357. The SSRL is a national user facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health (National Center for Research Resources, Biomedical Technology Program and the National Institute of General Medical Sciences). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. Genomic DNA from N. europaea strain ATCC 19718 (ATCC #19718D) was obtained from the American Type Culture Collection (ATCC).
References
Beste, G., Schmidt, F. S., Stibora, T. & Skerra, A. (1999). Proc. Natl Acad. Sci. USA, 96, 1898–1903. Web of Science CrossRef PubMed CAS Google Scholar
Bigelow, H. R., Petrey, D. S., Liu, J., Przybylski, D. & Rost, B. (2004). Nucleic Acids Res. 32, 2566–2577. Web of Science CrossRef PubMed CAS Google Scholar
Bishop, R. E. (2000). Biochim. Biophys. Acta, 1482, 73–83. Web of Science CrossRef PubMed CAS Google Scholar
Campanacci, V., Bishop, R. E., Blangy, S., Tegoni, M. & Cambillau, C. (2006). FEBS Lett. 580, 4877–4883. Web of Science CrossRef PubMed CAS Google Scholar
Charron, J. B., Ouellet, F., Houde, M. & Sarhan, F. (2008). BMC Plant Biol. 8, 86. Google Scholar
Cohen, A. E., Ellis, P. J., Miller, M. D., Deacon, A. M. & Phizackerley, R. P. (2002).
J. Appl. Cryst. 35, 720–726. Web of Science CrossRef CAS IUCr Journals Google Scholar
Cohen, S. X., Morris, R. J., Fernandez, F. J., Ben Jelloul, M., Kakaris, M., Parthasarathy,
V., Lamzin, V. S., Kleywegt, G. J. & Perrakis, A. (2004). Acta Cryst. D60, 2222–2229. Web of Science CrossRef CAS IUCr Journals Google Scholar
Collaborative Computational Project, Number 4 (1994). Acta Cryst. D50, 760–763. CrossRef IUCr Journals Google Scholar
Cruickshank, D. W. J. (1999). Acta Cryst. D55, 583–601. Web of Science CrossRef CAS IUCr Journals Google Scholar
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X.,
Murray, L. W., Arendall, W. B. III, Snoeyink, J., Richardson, J. S. & Richardson,
D. C. (2007). Nucleic Acids Res. 35, W375–W383. Web of Science CrossRef PubMed Google Scholar
Doerrler, W. T., Gibbons, H. S. & Raetz, C. R. (2004). J. Biol. Chem. 279, 45102–45109. Web of Science CrossRef PubMed CAS Google Scholar
Eichinger, A., Nasreen, A., Kim, H. J. & Skerra, A. (2007). J. Biol. Chem. 282, 31068–31075. Web of Science CrossRef PubMed CAS Google Scholar
Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132. Web of Science CrossRef CAS IUCr Journals Google Scholar
Flower, D. R., North, A. C. & Attwood, T. K. (1993). Protein Sci. 2, 753–761. CrossRef CAS PubMed Web of Science Google Scholar
Flower, D. R., North, A. C. & Sansom, C. E. (2000). Biochim. Biophys. Acta, 1482, 9–24. Web of Science CrossRef PubMed CAS Google Scholar
Goetz, D. H., Holmes, M. A., Borregaard, N., Bluhm, M. E., Raymond, K. N. & Strong,
R. K. (2002). Mol. Cell, 10, 1033–1043. Web of Science CrossRef PubMed CAS Google Scholar
Grzyb, J., Latowski, D. & Strzalka, K. (2006). J. Plant Physiol. 163, 895–915. Web of Science CrossRef PubMed CAS Google Scholar
Klock, H. E., Koesema, E. J., Knuth, M. W. & Lesley, S. A. (2008). Proteins, 71, 982–994. Web of Science CrossRef PubMed CAS Google Scholar
Korndorfer, I. P., Beste, G. & Skerra, A. (2003). Proteins, 53, 121–129. Web of Science CrossRef PubMed Google Scholar
Krishna, S. S., Weekes, D., Bakolitsa, C., Elsliger, M.-A., Wilson, I. A., Godzik,
A. & Wooley, J. (2010). Acta Cryst. F66, 1143–1147. Web of Science CrossRef IUCr Journals Google Scholar
Krissinel, E. & Henrick, K. (2007). J. Mol. Biol. 372, 774–797. Web of Science CrossRef PubMed CAS Google Scholar
Laskowski, R. A., Chistyakov, V. V. & Thornton, J. M. (2005). Nucleic Acids Res. 33, D266–D268. Web of Science CrossRef PubMed CAS Google Scholar
Lesley, S. A. et al. (2002). Proc. Natl Acad. Sci. USA, 99, 11664–11669. Web of Science CrossRef PubMed CAS Google Scholar
Leslie, A. G. W. (1992). Jnt CCP4/ESF–EACBM Newsl. Protein Crystallogr. 26. Google Scholar
Lomize, M. A., Lomize, A. L., Pogozheva, I. D. & Mosberg, H. I. (2006). Bioinformatics, 22, 623–625. Web of Science CrossRef PubMed CAS Google Scholar
Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. CrossRef CAS PubMed Web of Science Google Scholar
Olsson, M. G., Olofsson, T., Tapper, H. & Akerstrom, B. (2008). Free Radic. Res. 42, 725–736. Web of Science CrossRef PubMed CAS Google Scholar
Penuelas, J. & Munne-Bosch, S. (2005). Trends Plant Sci. 10, 166–169. Web of Science CrossRef PubMed CAS Google Scholar
Rao, A. V. & Rao, L. G. (2007). Pharmacol. Res. 55, 207–216. Web of Science CrossRef PubMed CAS Google Scholar
Roudkenar, M. H., Halabian, R., Ghasemipour, Z., Roushandeh, A. M., Rouhbakhsh, M.,
Nekogoftar, M., Kuwahara, Y., Fukumoto, M. & Shokrgozar, M. A. (2008). Arch. Med. Res. 39, 560–566. Web of Science CrossRef PubMed CAS Google Scholar
Sanchez, D., Lopez-Arias, B., Torroja, L., Canal, I., Wang, X., Bastiani, M. J. &
Ganfornina, M. D. (2006). Curr. Biol. 16, 680–686. Web of Science CrossRef PubMed CAS Google Scholar
Santarsiero, B. D., Yegian, D. T., Lee, C. C., Spraggon, G., Gu, J., Scheibe, D.,
Uber, D. C., Cornell, E. W., Nordmeyer, R. A., Kolbe, W. F., Jin, J., Jones, A. L.,
Jaklevic, J. M., Schultz, P. G. & Stevens, R. C. (2002). J. Appl. Cryst. 35, 278–281. Web of Science CrossRef CAS IUCr Journals Google Scholar
Schonfeld, P. & Wojtczak, L. (2008). Free Radic. Biol. Med. 45, 231–241. Web of Science CrossRef PubMed Google Scholar
Skerra, A. (2000). Biochim. Biophys. Acta, 1482, 337–350. Web of Science CrossRef PubMed CAS Google Scholar
Skerra, A. (2008). FEBS J. 275, 2677–2683. Web of Science CrossRef PubMed CAS Google Scholar
Soding, J., Biegert, A. & Lupas, A. N. (2005). Nucleic Acids Res. 33, W244–W248. Web of Science CrossRef PubMed Google Scholar
Tapiero, H., Townsend, D. M. & Tew, K. D. (2004). Biomed. Pharmacother. 58, 100–110. Web of Science CrossRef PubMed CAS Google Scholar
Terwilliger, T. C. (2002). Acta Cryst. D58, 2082–2086. CrossRef CAS IUCr Journals Google Scholar
Terwilliger, T. C. & Berendzen, J. (1999). Acta Cryst. D55, 849–861. Web of Science CrossRef CAS IUCr Journals Google Scholar
Vriend, G. (1990). J. Mol. Graph. 8, 52–56. CrossRef CAS PubMed Web of Science Google Scholar
Winn, M. D., Murshudov, G. N. & Papiz, M. Z. (2003). Methods Enzymol. 374, 300–321. Web of Science CrossRef PubMed CAS Google Scholar
Yang, H., Guranovic, V., Dutta, S., Feng, Z., Berman, H. M. & Westbrook, J. D. (2004).
Acta Cryst. D60, 1833–1839. Web of Science CrossRef CAS IUCr Journals Google Scholar
Ye, Y. & Godzik, A. (2004). Nucleic Acids Res. 32, W582–W585. Web of Science CrossRef PubMed CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.